RxDoctor Payments Data

Scott Bartley

Psychiatry · Dallas, TXNPI 1255342143

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,801 of the $2,158 with a category attached, or 83.5%. Avanir Pharmaceuticals, Inc. accounts for 94.5% of it on its own, with 1 other manufacturer making up the rest.

$2,158in general payments, 2019–2025

Across 16 payments — averaging $134.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$2K
  • Alkermes, Inc.$118
$42,729,163in research payments, 2019–2025

Across 3,176 payments — averaging $13,454 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sumitomo Pharma America, Inc.$11.4M
  • Teva Pharmaceuticals USA, Inc.$7.1M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$6.1M
  • Sunovion Pharmaceuticals Inc.$3.5M
  • E.r. Squibb & Sons, L.L.C.$3.3M
  • AbbVie$3M
  • plus $8.4M from 25 others

What the payments were for

  • Travel & lodging$1,80183%
  • Food & beverage$35717%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Avanir Pharmaceuticals, Inc.15$2,040
Alkermes, Inc.1$118

How this compares

$2,158 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Other psychiatry in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →